Solid Biosciences Inc. Current Assets
Solid Biosciences Inc. (SLDB) had Current Assets of $395.11 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $395.11M.
- 2026-03-31: Assets, Current $396.79M.
- 2025-12-31: Assets, Current $205.46M.
- 2025-09-30: Assets, Current $244.85M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $395.11M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $396.79M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $205.46M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $244.85M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $278.64M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $313.41M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $157.30M 10-K · filed 2026-03-19 |
| 2024-09-30 | $179.49M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $197.61M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $214.19M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $129.73M 10-K · filed 2025-03-06 |
| 2023-09-30 | $148.35M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $167.47M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $190.60M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $219.64M 10-K · filed 2024-03-13 |
| 2022-09-30 | $147.51M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $170.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $198.61M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $222.61M 10-K · filed 2023-03-23 |
| 2021-09-30 | $238.81M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $255.08M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $274.30M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $158.90M 10-K · filed 2022-03-14 |
| 2020-09-30 | $27.16M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $43.53M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $57.90M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $86.30M 10-K · filed 2021-03-15 |
| 2019-09-30 | $113.49M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $78.32M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $101.79M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $128.64M 10-K · filed 2020-03-12 |
| 2018-09-30 | $148.43M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $164.47M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $184.38M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $70.66M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |